Pyxis Oncology, Inc (PYXS) insider trading

Every open-market stock purchase and sale by Pyxis Oncology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • GordonMD Global Investments LP (10% owner) bought $51.5M in the last 90 days, growing their stake 55%.

Last 12 months: insiders bought $51.5M (2 buys) and sold $107K (1 sale). Last close $1.71 on Oct 22, 2026.

Recent PYXS insider trades

DateInsiderTradeValue
Oct 1, 2026GordonMD Global Investments LP (10% owner)Bought$26.4M
Oct 1, 2026GordonMD Global Investments LP (10% owner)Bought$25.1M
Oct 1, 2026GordonMD Global Investments LP (10% owner)Bought—
Sep 4, 2026Thomas Civik (CEO)Bought (not open market)—
Aug 20, 2026Jakob Dupont (Insider)Bought (not open market)—
Aug 12, 2026Thomas Civik (CEO)Bought (not open market)—
Jun 30, 2026Jakob Dupont (Insider)Sold$107K
Jun 30, 2026Jakob Dupont (Insider)Bought (not open market)$56K
Jun 30, 2026Jakob Dupont (Insider)Bought (not open market)—
Mar 24, 2026Jakob Dupont (Insider)Bought (not open market)—
Mar 24, 2026Michael A Metzger (Insider)Bought (not open market)—
Mar 24, 2026Santhosh Palani (Insider)Bought (not open market)—
Mar 24, 2026Rachel Humphrey (Insider)Bought (not open market)—
Mar 24, 2026Darren S Cline (Insider)Bought (not open market)—
Mar 24, 2026Jitendra Wadhane (Insider)Bought (not open market)—
Mar 24, 2026Jitendra Wadhane (Insider)Bought (not open market)—
Mar 24, 2026Freda C Lewis-Hall (Insider)Bought (not open market)—
Mar 24, 2026John L Flavin (Insider)Bought (not open market)—
Feb 3, 2026Thomas Civik (CEO)Bought (not open market)—

Who's trading PYXS

Get free alerts when an insider at Pyxis Oncology, Inc files a new trade →